Haemonetics Corporation
HAE
$57.17
$0.280.49%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.49M | 33.83M | 38.37M | 20.37M | 31.24M |
| Total Depreciation and Amortization | 29.03M | 29.22M | 29.14M | 19.04M | 23.53M |
| Total Amortization of Deferred Charges | -- | -- | -- | 9.38M | -- |
| Total Other Non-Cash Items | 7.78M | 15.61M | -12.35M | 2.70M | 11.75M |
| Change in Net Operating Assets | -30.54M | -29.84M | -82.58M | 12.59M | -67.06M |
| Cash from Operations | 43.77M | 48.82M | -27.42M | 64.08M | -540.00K |
| Capital Expenditure | -14.44M | -11.98M | -9.87M | -9.69M | -22.29M |
| Sale of Property, Plant, and Equipment | 251.00K | 189.00K | 20.36M | 551.00K | 338.00K |
| Cash Acquisitions | 0.00 | -1.76M | -149.15M | 0.00 | -243.85M |
| Divestitures | -- | -- | -- | 1.50M | -- |
| Other Investing Activities | -3.18M | -9.83M | -541.00K | -5.42M | -3.13M |
| Cash from Investing | -17.37M | -23.37M | -139.20M | -13.06M | -268.94M |
| Total Debt Issued | 0.00 | 0.00 | 950.00M | 0.00 | 110.00M |
| Total Debt Repaid | -1.56M | 0.00 | -587.76M | -63.50M | -3.50M |
| Issuance of Common Stock | 3.54M | 251.00K | 4.40M | 106.00K | 2.92M |
| Repurchase of Common Stock | -449.00K | -75.04M | -9.75M | 0.00 | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -149.00K | -11.00K | -23.20M | -108.00K | 54.00K |
| Cash from Financing | 1.38M | -74.80M | 333.69M | -63.50M | 109.43M |
| Foreign Exchange rate Adjustments | -6.21M | 4.20M | -1.45M | -2.70M | 3.02M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.56M | -45.15M | 165.63M | -15.18M | -157.03M |